Trial intelligence / Profile preview

Hyaluronidase and Ozone Therapy for Lumbosacral Spinal Canal Stenosis

IRCT20191004044980N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Oct 2019
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 3 trial of hyaluronidase and medical ozonated water in lumbar spinal stenosis (LSS), sponsored by Shiraz University of Medical Sciences. Started Oct 2019; status: completed.

02

Drugs

hyaluronidasemedical ozonated water
03

Conditions

lumbar spinal stenosis (LSS)

Beyond the preview

Go deeper on IRCT20191004044980N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191004044980N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call